232 related articles for article (PubMed ID: 25124555)
1. KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress.
Lezina L; Aksenova V; Ivanova T; Purmessur N; Antonov AV; Tentler D; Fedorova O; Garabadgiu AV; Talianidis I; Melino G; Barlev NA
Cell Death Differ; 2014 Dec; 21(12):1889-99. PubMed ID: 25124555
[TBL] [Abstract][Full Text] [Related]
2. SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.
Gu Y; Wang X; Liu H; Li G; Yu W; Ma Q
Oncol Rep; 2018 Oct; 40(4):1863-1874. PubMed ID: 30106440
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes.
Tin AS; Sundar SN; Tran KQ; Park AH; Poindexter KM; Firestone GL
Anticancer Drugs; 2012 Apr; 23(4):370-9. PubMed ID: 22185819
[TBL] [Abstract][Full Text] [Related]
4. Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression.
Chen L; Wei T; Si X; Wang Q; Li Y; Leng Y; Deng A; Chen J; Wang G; Zhu S; Kang J
J Biol Chem; 2013 May; 288(20):14510-14521. PubMed ID: 23543735
[TBL] [Abstract][Full Text] [Related]
5. Mixed lineage leukemia 5 (MLL5) protein regulates cell cycle progression and E2F1-responsive gene expression via association with host cell factor-1 (HCF-1).
Zhou P; Wang Z; Yuan X; Zhou C; Liu L; Wan X; Zhang F; Ding X; Wang C; Xiong S; Wang Z; Yuan J; Li Q; Zhang Y
J Biol Chem; 2013 Jun; 288(24):17532-43. PubMed ID: 23629655
[TBL] [Abstract][Full Text] [Related]
6. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
7. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation.
Abbas T; Shibata E; Park J; Jha S; Karnani N; Dutta A
Mol Cell; 2010 Oct; 40(1):9-21. PubMed ID: 20932471
[TBL] [Abstract][Full Text] [Related]
8. Api5 contributes to E2F1 control of the G1/S cell cycle phase transition.
Garcia-Jove Navarro M; Basset C; Arcondéguy T; Touriol C; Perez G; Prats H; Lacazette E
PLoS One; 2013; 8(8):e71443. PubMed ID: 23940755
[TBL] [Abstract][Full Text] [Related]
9. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signatures.
Wang Y; Alla V; Goody D; Gupta SK; Spitschak A; Wolkenhauer O; Pützer BM; Engelmann D
Nucleic Acids Res; 2016 Jan; 44(1):117-33. PubMed ID: 26350215
[TBL] [Abstract][Full Text] [Related]
11. Promoter occupancy of MLL1 histone methyltransferase seems to specify the proliferative and apoptotic functions of E2F1 in a tumour microenvironment.
Swarnalatha M; Singh AK; Kumar V
J Cell Sci; 2013 Oct; 126(Pt 20):4636-46. PubMed ID: 23868976
[TBL] [Abstract][Full Text] [Related]
12. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
Ofir M; Hacohen D; Ginsberg D
Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
[TBL] [Abstract][Full Text] [Related]
13. E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases.
Tyagi S; Herr W
EMBO J; 2009 Oct; 28(20):3185-95. PubMed ID: 19763085
[TBL] [Abstract][Full Text] [Related]
14. KMT Set7/9 is a new regulator of Sam68 STAR-protein.
Vasileva E; Shuvalov O; Petukhov A; Fedorova O; Daks A; Nader R; Barlev N
Biochem Biophys Res Commun; 2020 May; 525(4):1018-1024. PubMed ID: 32178870
[TBL] [Abstract][Full Text] [Related]
15. KMT Set7/9 affects genotoxic stress response via the Mdm2 axis.
Lezina L; Aksenova V; Fedorova O; Malikova D; Shuvalov O; Antonov AV; Tentler D; Garabadgiu AV; Melino G; Barlev NA
Oncotarget; 2015 Sep; 6(28):25843-55. PubMed ID: 26317544
[TBL] [Abstract][Full Text] [Related]
16. A novel function of HRP-3 in regulating cell cycle progression via the HDAC-E2F1-Cyclin E pathway in lung cancer.
Yun HS; Lee J; Kim JY; Sim YJ; Lee CW; Park JK; Kim JS; Ahn J; Song JY; Baek JH; Hwang SG
Cancer Sci; 2022 Jan; 113(1):145-155. PubMed ID: 34714604
[TBL] [Abstract][Full Text] [Related]
17. Set7/9 controls proliferation and genotoxic drug resistance of NSCLC cells.
Daks A; Mamontova V; Fedorova O; Petukhov A; Shuvalov O; Parfenyev S; Netsvetay S; Venina A; Kizenko A; Imyanitov E; Barlev N
Biochem Biophys Res Commun; 2021 Oct; 572():41-48. PubMed ID: 34343833
[TBL] [Abstract][Full Text] [Related]
18. X-linked inhibitor of apoptosis protein (XIAP) lacking RING domain localizes to the nuclear and promotes cancer cell anchorage-independent growth by targeting the E2F1/Cyclin E axis.
Cao Z; Li X; Li J; Luo W; Huang C; Chen J
Oncotarget; 2014 Aug; 5(16):7126-37. PubMed ID: 25216527
[TBL] [Abstract][Full Text] [Related]
19. A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors.
Edmond V; Merdzhanova G; Gout S; Brambilla E; Gazzeri S; Eymin B
Cell Cycle; 2013 Apr; 12(8):1267-78. PubMed ID: 23518498
[TBL] [Abstract][Full Text] [Related]
20. Methylation-mediated regulation of E2F1 in DNA damage-induced cell death.
Xie Q; Bai Y; Wu J; Sun Y; Wang Y; Zhang Y; Mei P; Yuan Z
J Recept Signal Transduct Res; 2011 Apr; 31(2):139-46. PubMed ID: 21320024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
